Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

fluorine F 18 RD2

A radioconjugate composed of the amyloid-beta-binding peptide RD2 labeled with the radionuclide fluorine F 18, with potential amyloid-beta peptide imaging activity upon positron emission topography (PET)/computed tomography (CT). Upon administration of fluorine F 18 RD2, RD2 targets and binds to amyloid-beta. Upon PET/CT imaging, amyloid-beta plaques can be visualized and detected. Amyloid-beta is a key component in plaque formation in Alzheimer's disease. Elevated plasma levels of amyloid-beta are also associated with some cancers.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:18F RD2
18F-labeled RD2
18F-RD2
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search